Pacer Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-7,186
| Closed | -$1.19M | – | 1499 |
|
|
2021
Q2 | $1.19M | Buy |
7,186
+301
| +4% | +$50.2K | 0.02% | 787 |
|
|
2021
Q1 | $1.06M | Sell |
6,885
-565
| -8% | -$76.7K | 0.02% | 749 |
|
|
2020
Q4 | $935K | Sell |
7,450
-7,913
| -52% | -$885K | 0.02% | 732 |
|
|
2020
Q3 | $1.56M | Buy |
+15,363
| New | +$1.57M | 0.03% | 514 |
|
|
2020
Q1 | – | Sell |
-21,487
| Closed | -$2.39M | – | 1204 |
|
|
2019
Q4 | $2.39M | Sell |
21,487
-1,084
| -5% | -$112K | 0.11% | 221 |
|
|
2019
Q3 | $2.24M | Sell |
22,571
-899
| -4% | -$89.3K | 0.05% | 437 |
|
|
2019
Q2 | $2.33M | Buy |
+23,470
| New | +$2.24M | 0.06% | 399 |
|
|
2018
Q4 | – | Sell |
-20,970
| Closed | -$2.31M | – | 1133 |
|
|
2018
Q3 | $2.31M | Buy |
20,970
+5,188
| +33% | +$540K | 0.09% | 275 |
|
|
2018
Q2 | $1.47M | Buy |
+15,782
| New | +$1.36M | 0.07% | 420 |
|
|
2017
Q4 | – | Sell |
-5,924
| Closed | -$451K | – | 1351 |
|
|
2017
Q3 | $451K | Buy |
5,924
+268
| +5% | +$20.3K | 0.04% | 726 |
|
|
2017
Q2 | $424K | Buy |
5,656
+1,691
| +43% | +$117K | 0.04% | 702 |
|
|
2017
Q1 | $259K | Buy |
3,965
+730
| +23% | +$43K | 0.03% | 819 |
|
|
2016
Q4 | $178K | Buy |
3,235
+547
| +20% | +$30K | 0.03% | 905 |
|
|
2016
Q3 | $152K | Buy |
+2,688
| New | +$132K | 0.02% | 912 |
|
Other funds holding PRAH
Pacer Advisors's PRAH Position: Q3 2021 in Review
Pacer Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 7,186 shares — an estimated $1.19M sold.
Pacer Advisors first reported a position in PRAH in Q3 2016 and held it in 14 quarters. The position peaked at $2.39M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Pacer Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Pacer Advisors sold 7,186 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.19M.
- Pacer Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 14 quarters.
- Pacer Advisors's PRA Health Sciences, Inc. position peaked at $2.39M in Q4 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Pacer Advisors's 13F filing for Q3 2021, filed 15 Oct 2021.